ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Decision analysis"

  • Abstract Number: 2525 • ACR Convergence 2025

    Point-of-Care Risk Factors for Systemic Disease in Patients Presenting with Small Vessel Vasculitis of the Skin

    Arjun Mahajan1, William Song2, Andrew Walls3, Arash Mostaghimi3, Robert Micheletti2 and Evan Piette3, 1Harvard Medical School, Boston, 2Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 3Brigham and Women's Hospital, Harvard Medical School, Boston

    Background/Purpose: Small vessel vasculitis (SVV) presenting in the skin may be skin-limited or a manifestation of systemic vasculitis or an underlying autoimmune disease. However, no…
  • Abstract Number: 2260 • ACR Convergence 2025

    Generative AI model identifies patients with Rheumatoid Arthritis (RA) months prior the diagnosis date: results from a large real-world RA cohort

    Shant Ayanian1, Siavash Rezaei2, Daniel Darveaux3, Marc Blasi3 and Elena myasoedova1, 1Mayo Clinic, Rochester, MN, 2Cerebras, Santa Clara, CA, 3Mayo Clinic, Rochester

    Background/Purpose: Clinical notes typically contain a valuable trove of information which is rarely used in predictive modeling given the complexity of working with unstructured data.…
  • Abstract Number: 1988 • ACR Convergence 2025

    Advancing Vascular Assessment: Combining NIRS-VOT and Ultrasound-Based Brachial Artery Diameter for Improved Diagnostics in Healthy Controls and APS

    Soongho Park1, Julie Mathew1, Sharon Osgood2, Claudia Gomez1, Eric Leifer1, Ecem Sevim1 and Yogendra Kanthi3, 1NIH, Bethesda, 2NHLBI/NIH, Bethesda, 3National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

    Background/Purpose: Near-Infrared Spectroscopy combined with Vascular Occlusion Test (NIRS-VOT) is a non-invasive diagnostic method for assessing microvascular function. However, its diagnostic accuracy is often limited…
  • Abstract Number: 1186 • ACR Convergence 2025

    Increased Adoption of IL-1 Pathway Inhibition and the Steroid-sparing Paradigm Shift: Temporal Trends in Recurrent Pericarditis Treatment From the RESONANCE Patient Registry

    Paul Cremer1, Michael Garshick2, Sushil Allen Luis3, Ajit Raisinghani4, Brittany Weber5, Vidhya Parameswaran6, Allison Curtis6, Sue Gibbons6, Allan Klein7 and John Paolini6, 1Cleveland Clinic, Shaker Heights, OH, 2NYU Langone Health, Tenafly, NJ, 3Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, 4Division of Cardiology, Department of Medicine, Sulpizio Cardiovascular Center, University of California San Diego, San Diego, CA, 5Brigham and Women's Hospital, DEDHAM, MA, 6Kiniksa Pharmaceuticals, LEXINGTON, MA, 7Cleveland Clinic, Cleveland, OH

    Background/Purpose: Recurrent pericarditis (RP) is a chronic autoinflammatory disease mediated by IL-1 that requires long-term treatment. While the 2015 European Society of Cardiology Guidelines position…
  • Abstract Number: 1052 • ACR Convergence 2025

    “Prednisone… A Necessary Evil…” Developing an Evidence-Based Benefits vs. Harms Shared Decision-Making Tool (PRED-SAFE) to Support Decisions Around Chronic Prednisone Use

    Isabella Hartel1, Jay Patel1, Justin Levinson1, Sancia Ferguson2, Carmen Campbell1, Amannda Weber3, Shelby Gomez4, David Gazeley5, Ali Duarte-Garcia6, Jennifer Barton7 and Shivani Garg8, 1University of Wisconsin, School of Medicine and Public Health, Madison, Madison, WI, 2University of Wisconsin School of Medicine and Public Health, Madison, Madison, WI, 3University of Wisconsin (UW), UW Health, Madison, WI, 4University of Wisconsin, School of Pharmacy, Madison, WI, 5Medical College of Wisconsin, Milwaukee, WI, 6Mayo Clinic, Rochester, MN, 7VA Portland Health Care System/OHSU, Portland, OR, 8University of Madison, School of Medicine and Public Health, Madison, WI

    Background/Purpose: Guidelines recommend limiting chronic prednisone use ( >5 mg/d for >3-6 mos.) given higher risks of fractures, infections, and damage. Yet, patients struggle to…
  • Abstract Number: 1051 • ACR Convergence 2025

    Mitigating Hydroxychloroquine (HCQ) Nonadherence by Clarifying Misbeliefs Using a Shared Decision-Making Tool (HCQ-SAFE©) Across Two Different Rheumatology Centers

    Isabella Hartel1, David Gazeley2, Jay Patel1, Betty Chewning3, Shelby Gomez4, Jessica Michaud5, Laura Dickmann6, Jon keevil7, Patricia Tellez-giron1, Christie Bartels8 and Shivani Garg9, 1University of Wisconsin, School of Medicine and Public Health, Madison, Madison, WI, 2Medical College of Wisconsin, Milwaukee, WI, 3University of Wisconsin, School of Pharmacy, Madison, 4University of Wisconsin, School of Pharmacy, Madison, WI, 5Medical College of Wisconsin, Milwaukee, Madison, WI, 6Medical College of Wisconsin, Milwaukee, Milwaukee, 7N/A, Madison, 8University of Wisconsin School of Medicine and Public Health, Madison, WI, 9University of Madison, School of Medicine and Public Health, Madison, WI

    Background/Purpose: Hydroxychloroquine (HCQ) prolongs disease-free and damage-free survival in lupus (SLE). Yet, ~80% of patients stop taking HCQ resulting in poor outcomes including early mortality.…
  • Abstract Number: 1050 • ACR Convergence 2025

    Bridging the Gap: A Mixed-Methods Study to Enhance Integration of HCQ-SAFE, A Shared Decision-Making Tool for Hydroxychloroquine Use, in Routine Lupus Care

    Isabella Hartel1, Jay Patel1, David Gazeley2, Drake Johnson1, Justin Levinson1, Carmen Campbell1, Britney Youngchild3, Shelby Gomez3, Amannda Weber4, Jessica Michaud5, Laura Dickmann6, Sancia Ferguson7, Betty Chewning8, Christie Bartels9 and Shivani Garg10, 1University of Wisconsin, School of Medicine and Public Health, Madison, Madison, WI, 2Medical College of Wisconsin, Milwaukee, WI, 3University of Wisconsin, School of Pharmacy, Madison, WI, 4University of Wisconsin (UW), UW Health, Madison, WI, 5Medical College of Wisconsin, Milwaukee, Madison, WI, 6Medical College of Wisconsin, Milwaukee, Milwaukee, 7University of Wisconsin School of Medicine and Public Health, Madison, Madison, WI, 8University of Wisconsin, School of Pharmacy, Madison, 9University of Wisconsin School of Medicine and Public Health, Madison, WI, 10University of Madison, School of Medicine and Public Health, Madison, WI

    Background/Purpose: Hydroxychloroquine (HCQ) is a key therapy for lupus (or SLE). Yet, challenged to weigh benefits vs. harms, ~80% of patients self-discontinue HCQ. Shared decision-making…
  • Abstract Number: 0449 • ACR Convergence 2025

    Consistency of CDAI Low-Disease Activity (LDA) Outcomes with Time in a Large US Registry: Association With Patient-Reported Clinical Outcomes and Measures of Quality of Life

    Joel Kremer1, Kevin Kane2, George Reed3 and Michael Weinblatt4, 1The Corrona Research Foundation, Delray Beach, FL, 2U of Mass Medical School, Worcester, MA, MA, 3University of Massachusetts Chan Medical School, Worcester, MA, 4Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Low disease activity has been identified as a treatment goal for the treatment of RA. A singlecenter RA registry (BRASS) reported a difference in…
  • Abstract Number: 1315 • ACR Convergence 2024

    From Presentation to Publication: Tracking the Publication Rate of Abstracts Presented at American College of Rheumatology Convergence Conference in the Years 2015 and 2018

    Shreena Kamlesh Gandhi1, Shivani Patel2, Saransh Narang3, Aayushi Rajani3 and Kaleb Michaud4, 1KU School of Medicine, Wichita, Wichita, KS, 2Washington University in St. Louis, St. Louis, MO, 3Medical College, Baroda, Baroda, India, 4University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: The ACR Convergence meeting attracts rheumatology researchers worldwide to present their peer- reviewed abstracts for a global audience either as a poster or oral…
  • Abstract Number: 1358 • ACR Convergence 2024

    A Step Towards Personalised Medicine – Development and Efficacy of Machine Learning Based Smart-Web Application for Prediction of Steroid Induced Hyperglycemia in Patients with Rheumatoid Arthritis and Other Autoimmune Rheumatic Diseases

    Manyam Prudhvi Krishna1, Sandeep Surendran1, MITHUN CHALAKKARAYIL BHAGAVALDAS2, Sundarakrishna Sai3, Sekhar V Easwar1, Ronith S Kumar3 and Manu Pradeep1, 1Amrita Institute of Medical Sciences, Kochi, Kerala, India, 2Amrita Institute of Medical Sciences, ERNAKULAM, Kerala, India, 3Amrita Vishwa Vidyapeetham, Kochi, Kerala, India

    Background/Purpose: Steroids play a key role in treating rheumatic diseases due to their anti-inflammatory effects. However, long-term or high-dose use leads to side effects like…
  • Abstract Number: 2395 • ACR Convergence 2024

    Validation Cohort of a Tool to Predict Proliferative Histological Class in Lupus Nephritis Based on Clinical and Laboratory Data – LUCAS Study (Lupus Nephritis Class Assessment System)

    Antônio Silaide De Araújo-Júnior1, Emília Sato2, Alexandre Wagner Silva de Souza1, Fábio Jennings1, Gianna Mastroianni Kirsztajn3, Ricardo Sesso3 and Edgard Reis Neto4, 1Division of Rheumatology, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil., São Paulo, SP, Brazil, 2Universidade Federal de Sao Paulo, São Paulo, SP, Brazil, 3Division of Nephrology, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil., São Paulo, SP, Brazil, 4Division of Rheumatology, Department of Medicine, Escola Paulista de Medicina, Universidade Federal, São Paulo, SP, Brazil

    Background/Purpose: Lupus nephritis (LN) is an important cause of morbidity and mortality in patients with systemic lupus erythematosus (SLE), and kidney biopsy is the gold…
  • Abstract Number: 2605 • ACR Convergence 2024

    Clarifying Misbeliefs & Resolving Decisional Conflicts About Hydroxychloroquine (HCQ) Through a Shared Decision-Making Tool (HCQ-SAFE©)

    Shivani Garg1, Jay Patel1, Sancia Ferguson2, Betty Chewning3, Shelby Gomez4, Jon keevil5, David Gazeley6, Patricia Tellez-Giron1 and Christie Bartels7, 1University of Wisconsin, School of Medicine and Public Health, Madison, Madison, WI, 2University of Wisconsin, Madison, Madison, WI, 3University of Wisconsin, School of Pharmacy, Madison, 4UW Health, Madison, 5N/A, Madison, 6Medical College of Wisconsin, Wauwatosa, WI, 7University of Wisconsin School of Medicine and Public Health, Madison, WI

    Background/Purpose: Treatment of lupus (or SLE) is complex, especially for young patients who are committed to take hydroxychloroquine (HCQ) lifelong, which carries some risk, albeit…
  • Abstract Number: 0375 • ACR Convergence 2024

    Patient Outcomes During the Implementation of a Patient Decision-Aid for a Diverse Population of Systemic Lupus Erythematosus: A Study in 15 U.S. Rheumatology Clinics

    Jasvinder Singh1, Larry Hearld2, Walter Chatham3, Sonali Narain4, Narender Annapureddy5, Diane Kamen6, Kimberly Trotter7, vikas Majithia8, Zineb Aouhab9, Swamy Venuturupalli10, Daniel Wallace11, rosalind Ramsey-Goldman12, Alfred Kim13, Maureen McMahon14, S. Sam Lim15, Kalpana Bhairavarasu16, Alexa Meara17, Kenneth Kalunian18 and Cathy Lee Ching19, 1Baylor College of Medicine, Birmingham, AL, 2University of Alabama at Birmingham (UAB), Birmingham, AL, 3University of Nevada, Las Vegas, Las Vegas, NV, 4Northwell Health, Great Neck, NY, 5Vanderbilt University Medical Center, Nashville, TN, 6Medical University of South Carolina, Charleston, SC, 7University of Chicago, Chicago, IL, 8University of Missisippi Medical Center (UMC), Jackson, MS, 9Loyola University Medical Center, Oak Brook, IL, 10Attune Health, Beverly Hills, CA, 11Cedars Sinai Medical Center, Studio City, CA, 12Northwestern University, Chicago, IL, 13Washington University School of Medicine, Division of Rheumatology, Department of Medicine, St Louis, MO, 14UCLA David Geffen School of Medicine, Los Angeles, CA, 15Emory University, Atlanta, GA, 16Baylor College of Medicine, Sugar Land, TX, 17The Ohio State University Wexner Medical Center, COLUMBUS, OH, 18University of California San Diego, La Jolla, CA, 19UMMC, Jackson, MS

    Background/Purpose: To implement a self-administered patient decision-aid (PtDA) for lupus in outpatient clinics, assess its reach/penetration within each clinic, and examine patient outcomesMethods: An effective…
  • Abstract Number: 1237 • ACR Convergence 2024

    The Art of Choosing Together: Unveiling the Patient’s Perspective in Rheumatology

    ADRIANA VANEGAS1, Guillermo Quiceno2, Luis Lira3, Gina Ochoa4, Álvaro Arbeláez-Cortés5, Mauricio Restrepo-Escobar6 and Virginia Pascual Ramos7, 1HOSPITAL SAN VICENTE FUNDACION - UNIVERSIDAD DE ANTIOQUIA - Asociación Colombiana de Reumatología (ASOREUMA), MEDELLIN, Colombia, 2University of Tennessee Graduate School of Medicine, Dallas, TX, 3Sociedad Chilena de Reumatología, Santiago, Chile, 4Fundación LICAR, Barranquilla, Colombia, 5Clínica IMBANACO, Cali, Colombia, 6Universidad de Antioquia, Retiro, Colombia, 7Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Federal District, Mexico

    Background/Purpose: Scientific evidence supports that shared decision-making (SDM) can improve adherence to treatment, patient satisfaction, quality of life, clinical outcomes, and healthcare costs. However, challenges…
  • Abstract Number: 1306 • ACR Convergence 2024

    A Comparative Analysis of ChatGPT-4, Microsoft’s Bing and Google’s Bard at Answering Rheumatology Clinical Questions

    Pitchaporn Yingchoncharoen1, Nattanicha Chaisrimaneepan2, watsachon Pangkanon1 and Jerapas Thongpiya1, 1Texas Tech Health Sciences Center, Lubbock, TX, 2Texas Tech University Health Sciences Center, Lubbock, TX

    Background/Purpose: The role of artificial intelligence (AI) is rapidly expanding in medical fields, with an increased frequency of use by both patients and providers. There…
  • 1
  • 2
  • 3
  • …
  • 5
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology